The physiology and clinical utility of anti-Mullerian hormone in women. - sprookjes - yvandenbroek - TriplyDB

The physiology and clinical utility of anti-Mullerian hormone in women.

The physiology and clinical utility of anti-Mullerian hormone in women.

http://www.wikidata.org/entity/Q34398233

about

Anti-Mullerian Hormone: Above and Beyond Conventional Ovarian Reserve Markers Role of Anti-Müllerian Hormone in pathophysiology, diagnosis and treatment of Polycystic Ovary Syndrome: a review Maximizing the clinical utility of antimüllerian hormone testing in women's health Prevention of Ovarian Hyperstimulation Syndrome: A Review Endocrinopathies in survivors of childhood neoplasia Alcohol, cigarette smoking, and ovarian reserve in reproductive-age African-American women AMH/MIS as a contraceptive that protects the ovarian reserve during chemotherapy Omega-3 Fatty Acid Supplementation Lowers Serum FSH in Normal Weight But Not Obese Women.Positive correlations of age and parity with plasma anti-Müllerian hormone concentrations in Japanese Black cows Ovarian Damages Produced by Aerosolized Fine Particulate Matter (PM2.5) Pollution in Mice: Possible Protective Medications and Mechanisms Biological variability in serum anti-Müllerian hormone throughout the menstrual cycle in ovulatory and sporadic anovulatory cycles in eumenorrheic women.Anti-Müllerian hormone (AMH) as a good predictor of time of menopause A highly-sensitive anti-Müllerian hormone assay improves analysis of ovarian function following chemotherapy for early breast cancer.Sexual dysfunction and infertility as late effects of cancer treatment.Fertility options in transgender people.Intraovarian control of early folliculogenesis Anti-Muellerian hormone levels in plasma of Holstein-Friesian heifers as a predictive parameter for ovum pick-up and embryo production outcomes OvAge: a new methodology to quantify ovarian reserve combining clinical, biochemical and 3D-ultrasonographic parameters.Anti-Müllerian hormone concentrations in premenopausal women and breast cancer risk Comparison of Specificity and Sensitivity of AMH and FSH in Diagnosis of Premature Ovarian Failure.Cell-free DNA in Human Follicular Microenvironment: New Prognostic Biomarker to Predict in vitro Fertilization Outcomes.Does AMH Reflect Follicle Number Similarly in Women with and without PCOS?Chronic Pelvic Inflammation Diminished Ovarian Reserve as Indicated by Serum Anti Mülerrian Hormone.Predicting Ovarian Activity in Women Affected by Early Breast Cancer: A Meta-Analysis-Based Nomogram Changes in Circulating ProAMH and Total AMH during Healthy Pregnancy and Post-Partum: A Longitudinal Study.The original Beckman Coulter Generation II assay significantly underestimates AMH levels compared with the revised protocol Attenuated AMH signaling pathway plays an important role in the pathogenesis of ovarian hyperstimulation syndrome.Genome-wide association study identifies common and low-frequency variants at the AMH gene locus that strongly predict serum AMH levels in males.Reduced ovarian reserve relates to monocyte activation and subclinical coronary atherosclerotic plaque in women with HIV The anti-Müllerian hormone (AMH) acts as a gatekeeper of ovarian steroidogenesis inhibiting the granulosa cell response to both FSH and LH Analgesic exposure in pregnant rats affects fetal germ cell development with inter-generational reproductive consequences Assessment of the Access AMH assay as an automated, high-performance replacement for the AMH Generation II manual ELISA.Circulating microRNAs in follicular fluid, powerful tools to explore in vitro fertilization process Does polycystic ovarian morphology influence the response to treatment with pulsatile GnRH in functional hypothalamic amenorrhea?IVF results in patients with very low serum AMH are significantly affected by chronological age Anti-Müllerian hormone promotes pre-antral follicle growth, but inhibits antral follicle maturation and dominant follicle selection in primates.Antimüllerian hormone among women with and without type 1 diabetes: the Epidemiology of Diabetes Interventions and Complications Study and the Michigan Bone Health and Metabolism Study.No common denominator: a review of outcome measures in IVF RCTs.Reference Values for the Revised Anti-Müllerian Hormone Generation II Assay: Infertile Population-based Study.The regulation and assessment of follicular growth.

P2860

Q26765770-720A37FE-B3DA-49F5-8200-D8F5188AD6F5 Q26774060-07A468B5-A216-4D2F-8537-301D4D1C79E7 Q26822937-56AB8A9E-9490-46C2-B846-E2F4CDE2D0EF Q26828442-8D44C252-3908-4DDB-9D98-48AFBD550CDA Q27009171-FE318305-81DF-465E-94B1-777F1F19F53C Q28394989-A7BF554F-8F6E-41FD-9DAA-A67ACB120E1F Q30353654-1755D08F-EB74-4651-8B66-B793EF5BEEF6 Q30354624-32F23F42-64CB-4321-B725-52896537BCE9 Q33593114-16B4B30C-96C1-42D7-8C9B-2E88E1258786 Q33776849-863D2483-D55D-4CAC-89BE-A4FCEE38A1F9 Q33888297-911F77F5-D442-4449-8A71-191D905C9330 Q33903528-0C9CC991-9FF0-461F-ACE5-066F8F97FA9C Q34199333-4EB3FFB2-9165-4414-B328-4FFA4DB1DCA8 Q34604454-AA56AEEE-FDB6-4E54-B67D-26F9590EB69D Q34675544-12A32144-1F32-4833-823C-0C9C7B9DD6D0 Q35024088-B8C8080A-FDCD-4A78-BE5A-7B3C6984436C Q35161040-AC77F68B-59FC-4885-9A1F-D8D732F50EB2 Q35354540-7FA47A50-DC19-4DDA-9B9D-680ED502DE75 Q35675000-63DED7B7-B771-4612-8240-6542E9F3974B Q35737773-234430DD-CF71-4178-BD16-79AA2513640D Q35750317-F150944F-3A95-48DD-B6F7-5D9876479BA6 Q35901133-0A262233-722C-43AD-80E2-BDE0447C3B4E Q36043997-B30DC358-2DD4-4ED7-8C5F-76C5F2B6AB65 Q36116355-C77B8145-6968-4A77-B96F-E840912A137D Q36128530-DC947D2F-7BD0-4A05-8B2F-DFA94C444B02 Q36297167-25B48495-BF9E-4C29-BA3B-5673F5123EF6 Q36309513-DEC2EA93-B169-4128-885F-1971F169A8EC Q36444589-3AF4A118-39EB-4D51-930F-E5955355FE7E Q36463715-A5AA57BF-F0A4-437E-9958-5DD2110DA2CC Q36474823-D3B36AB6-3A31-4AE9-8E39-2472718DC6B6 Q36506779-75E53CC8-D0CB-414A-A16B-78689B2E077A Q36584093-3D7AF01A-29C2-4FFE-91C6-83F5393BD5EF Q36824056-7091EC7D-F100-4CDC-B003-369BF5732339 Q36850918-EA9F75F9-B052-4A66-AF4F-99365A9E1642 Q36910187-BF3E0717-EEFA-4C2B-B551-EDE642EAC473 Q36991844-721522B0-ED85-4DE2-857B-E440B949F408 Q37507092-870B1D1A-410A-4E0D-A7EF-83DC64E25CD6 Q37540833-D64BD5EB-8250-458E-AAF1-88FE3EC416A0 Q37740486-E2A50E59-AF7B-451D-A2A2-E31613C06A42 Q38235994-0B21F301-0085-46FB-8A09-D1F36815236A

P2860

The physiology and clinical utility of anti-Mullerian hormone in women.

http://www.wikidata.org/entity/Q34398233

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

The physiology and clinical utility of anti-Mullerian hormone in women.

@ast

The physiology and clinical utility of anti-Mullerian hormone in women.

@en

The physiology and clinical utility of anti-Mullerian hormone in women.

@nl

type

label

The physiology and clinical utility of anti-Mullerian hormone in women.

@ast

The physiology and clinical utility of anti-Mullerian hormone in women.

@en

The physiology and clinical utility of anti-Mullerian hormone in women.

@nl

prefLabel

The physiology and clinical utility of anti-Mullerian hormone in women.

@ast

The physiology and clinical utility of anti-Mullerian hormone in women.

@en

The physiology and clinical utility of anti-Mullerian hormone in women.

@nl

P1433

Q34398233-26A1A903-7A2C-40D6-84E6-E0CF36750656

P1476

Q34398233-7EC8E69F-B70B-4188-A941-5505909A648A

P2093

Q34398233-06486EFF-13F4-4229-B480-067612A08080

Q34398233-110541F8-65A4-4404-8CDE-CD81E3EACB0B

Q34398233-20D1262C-F8F1-41D8-B316-D3C25866E7C0

Q34398233-45640498-DA9C-4317-A635-CBB195FD8235

Q34398233-5926208D-959D-406B-93A0-EC4DA6447233

Q34398233-5AF6A9AB-047D-4C39-8D00-0168133C9EF4

Q34398233-7500EE8E-7C0E-4B21-A314-1F8D242E003E

Q34398233-7B5F6291-5C9A-4D0F-B583-DAB405C90CF7

Q34398233-E9B3E11D-8A14-4C31-BEAD-100DB5EA4DCD

P2860

Q34398233-0298DB87-BA5A-4AC0-BEBD-AD179830B8A0

Q34398233-0447BC6D-76F3-4E46-B95F-A2A9525AE1A2

Q34398233-08CCC132-E196-4086-B396-72506D7D9B8B

Q34398233-09E02D55-CC91-48D8-91F0-2BB17F8B8872

Q34398233-0A83F46C-2391-4DF1-8573-D5ECA6D0869D

Q34398233-0D359762-8BB2-4A34-8362-D28673E96B1B

Q34398233-0D55FE88-140F-4F4A-8ADB-C20D1CF2DBB4

Q34398233-11A65B4C-02DC-4383-9C37-CCA4D6EDFF8C

Q34398233-1455611B-A62D-47CE-BD6F-78FD2A980262

Q34398233-15678874-83BD-4EE3-B380-79AD2FE8AF67

P304

Q34398233-98313C3F-2618-4AC6-9AAB-4181C62DCFB1

P31

Q34398233-550CAB68-CA77-4D43-AC47-8C599C26E0F0

P356

Q34398233-7A1DE1CC-5190-48FB-89AC-FFD29B9130ED

P433

Q34398233-393645A7-4B19-4E04-8F8D-2CD8264CDA3E

P478

Q34398233-0B916CCB-C3DC-4A09-ADEE-7739D7728B91

P50

Q34398233-145BA608-E2A6-4057-8058-3078F6A3A0D1

Q34398233-1B1F3BF1-539F-4098-91C6-EE3EBADC2274

Q34398233-34F2311C-DA1F-485E-970B-0DE3474D20BA

Q34398233-783A2022-8461-4798-B60D-3360754340AC

Q34398233-8048BCEB-415E-4AB8-8553-9270AC92B346

Q34398233-DFFC6CC0-AD7E-401C-88C3-37E5289E32DD

P577

Q34398233-A47F48C0-1853-4FDA-97FD-8DEDA6EDD43A

P5875

Q34398233-6E69571E-F201-41F0-BF74-D59826A6F0B3

P698

Q34398233-79E28690-9639-41F9-B255-764EF1A01A93

P356

P1433

Human Reproduction Update

P1476

The physiology and clinical utility of anti-Mullerian hormone in women.

@en

P2093

Adam Balen

http://www.w3.org/2001/XMLSchema#string

Cornelius Lambalk

http://www.w3.org/2001/XMLSchema#string

Frank Broekmans

http://www.w3.org/2001/XMLSchema#string

Georg Griesinger

http://www.w3.org/2001/XMLSchema#string

Helen Mason

http://www.w3.org/2001/XMLSchema#string

Jenny A Visser

http://www.w3.org/2001/XMLSchema#string

Nafi Dilaver

http://www.w3.org/2001/XMLSchema#string

Renato Fanchin

http://www.w3.org/2001/XMLSchema#string

Richard A Anderson

http://www.w3.org/2001/XMLSchema#string

P2860

A validated model of serum anti-müllerian hormone from conception to menopause

Human ovarian reserve from conception to the menopause

Gonadotrophin-releasing hormone antagonists for assisted reproductive technology

Isolation of the bovine and human genes for Müllerian inhibiting substance and expression of the human gene in animal cells

Bioactivation of Müllerian inhibiting substance during gonadal development by a kex2/subtilisin-like endoprotease

Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach

AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis

Pretreatment antimüllerian hormone levels determine rate of posttherapy ovarian reserve recovery: acute changes in ovarian reserve during and after chemotherapy

Impact of cancer therapies on ovarian reserve

Impact of breast cancer on anti-mullerian hormone levels in young women

P304

370-385

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/HUMUPD/DMT062

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

Antonio La Marca

Thomas W. Kelsey

Scott M. Nelson

Claus Yding Andersen

Didier Dewailly

P577

2014-01-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259767417

http://www.w3.org/2001/XMLSchema#string

P698

24430863

http://www.w3.org/2001/XMLSchema#string